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Purpose: Immune activation with T cell tumor infiltration is beneficial for the prognosis of
patients suffering from solid cancer. Depending on their immune status, solid tumors can be
immunologically classified into three groups: “hot” tumors are infiltrated with T lympho-
cytes, “cold” tumors are not infiltrated and “immune excluded” tumors are only infiltrated in
the peripheral tumor tissue. Checkpoint inhibitors provide new therapeutic options for “hot”
tumors by triggering the immune response of T cells. In order to enable this for cold tumors
as well, T cells must be enriched in the tumor. Therefore, we use the principle of magnetic
targeting to guide T cells loaded with citrate-coated superparamagnetic iron oxide nanopar-
ticles (SPIONCitrate) to the tumor by an externally applied magnetic field.
Methods: SPIONCitrate were produced by alkaline coprecipitation of iron(II) and iron(III)
chloride and in situ coating with sodium citrate. The concentration-dependent cytocompat-
ibility of the particles was determined by flow cytometry and blood stability assays. Atomic
emission spectroscopy was used for the quantification of the particle uptake into T lympho-
cytes. The attractability of the loaded cells was observed by live-cell imaging in the presence
of an externally applied magnetic field.
Results: SPIONCitrate displayed good cytocompatibility to T cells and did not show any sign
of aggregation in blood. Finally, SPIONCitrate-loaded T cells were strongly attracted by a
small external magnet.
Conclusion: T cells can be “magnetized” by incorporation of SPIONCitrate for magnetic
targeting. The production of the particle-cell hybrid system is straightforward, as the loading
process only requires basic laboratory devices and the loading efficiency is sufficient for cells
being magnetically controllable. For these reasons, SPIONCitrate are potential suitable candi-
dates for magnetic T cell targeting.
Keywords: magnetic targeting, biocompatibility, immunoaffinity chromatography, cold
tumor, T cell
Introduction
According to World Health Organization (WHO) data, in 2018, cancer was the
second leading cause of death with about 10 million deaths worldwide. In addition,
there were over 18 million new cases of cancer in 2018.1 Solid tumors are
responsible for more than 90% of all tumor diseases. For the prognosis of these
patients, tumor-infiltrating lymphocytes (TILs) play an important role.2–5 The
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number of TILs has a large influence on the patient's
outcome, since T lymphocytes are responsible for the
immune activation against the tumor.6–8 Depending on
the amount and localization of TILs, solid tumors can be
immunologically divided into “hot”, “immune excluded”
and “cold” tumors.9 “Hot” means that the tumor is infil-
trated by T lymphocytes, but does not necessarily trigger
an immune response. In “immune excluded” tumors, T
cells only penetrate into peripheral tissue. “Cold” tumors
are not infiltrated by the immune system at all due to
various mechanisms. In the case of hot tumors, immune
checkpoint inhibitors such as nivolumab and ipilimumab
are able to trigger an activation of the T cell immune
response in the infiltrated tumor by blocking inhibitory
signals of the tumor towards T cells.10,11 However, this
type of therapy only works if there is a sufficient number
of T lymphocytes in the tumor, which is not the case for
cold tumors. In order to achieve the transfer from cold to
hot, T lymphocytes must be accumulated in the tumor
area.12 One possibility is the use of a bispecific antibody
that simultaneously binds to T lymphocytes and to specific
sites on the tumor.13 However, this system has some dis-
advantages since bispecific antibodies are cost-intensive
and interact very selectively.14 In addition, there is a risk
that the extracellularly bound antibodies may cause
adverse immune reactions.15 To overcome these chal-
lenges, the magnetic cell trafficking method could be
more widely applicable. The superparamagnetic properties
of the superparamagnetic iron oxide nanoparticles
(SPIONs) are used to magnetically attract cells loaded
with these SPIONs comparable to magnetic drug
targeting.16–18 The cells are loaded with biocompatible
SPIONs, purified, applied to the desired site and concen-
trated in this area with an external magnetic field.19–21
Hence, with this method, various cell types such as stem
cells, T cells or dendritic cells can be functionalized and
applied to any tumor with an accessible blood supply.22,23
In a preliminary study, we recently demonstrated the
feasibility to load T cells with SPIONs and to attract them
with an external magnetic field.24 The SPIONs used, how-
ever, were either too cytotoxic or coated with bovine
serum albumin, which would lead to immune reactions in
humans. Human serum albumin was also used instead to
prevent immune reactions, but this led to insufficient par-
ticle uptake into the cells. With regard to future in vivo
application in animals or humans, SPIONs therefore have
to be coated with a cyto- and immunocompatible layer.
Additionally, the cellular loading of the particles must be
adequate and the particles need a sufficiently high mag-
netic susceptibility. Moreover, after loading, it is necessary
to be able to separate cells and excess SPIONs from each
other. Particle stability in the blood is also important to
avoid thromboembolic events caused by particle agglom-
eration of released particles during future in vivo applica-
tion. These are the reasons why for this work, we used
SPIONs coated in situ with citrate (SPIONCitrate). The
particles were physicochemically characterized and tested
in vitro for blood stability and cell toxicity in T lympho-
cytes. Subsequently, the particle uptake into T cells was
investigated and quantified. Finally, the magnetizability of
the system consisting of T cells loaded with SPIONCitrate
was tested and visualized.
Materials And Methods
Materials
Sodium citrate dihydrate, iron(II) chloride tetrahydrate
and iron(III) chloride hexahydrate were supplied by
Merck (Darmstadt, Germany), ammonia solution 25%,
acetone, methanol, nitric acid 65%, ethylenediaminete-
traacetic acid disodium salt dihydrate (EDTA), D(+)-bio-
tin, crystal violet (C.I. 42555), citric acid monohydrate
and di-sodium hydrogen phosphate by Carl Roth
(Karlsruhe, Germany). Penicillin/streptomycin solution
(5000 U/mL), GlutaMAX supplement, Hoechst 33342
(Hoe), Annexin A5 FITC conjugate (AxV), DiIC1(5)
(1,1′-dimethyl-3,3,3′,3′-tetramethylindodicarbocyanine
iodide, DiI), dimethyl sulfoxide (DMSO), Zeba Spin
desalting columns (0.5 mL, MWCO 7 kDa) and EZ-
Link Sulfo-NHS-LC-Desthiobiotin (no weigh format)
were obtained from Thermo Fisher Scientific (Waltham,
MA, USA). Phosphate-buffered saline (PBS), propidium
iodide (PI), 2ʹ,7ʹ-dichlorofluorescin diacetate (DCFH-DA)
and Lucifer Yellow CH dipotassium salt (LY) were pur-
chased from Sigma-Aldrich (Taufkirchen, Germany),
Ringer's solution from Fresenius Kabi (Bad Homburg,
Germany). Dulbecco's modified Eagle`s medium
(DMEM) and fetal calf serum (FCS) were provided by
Biochrom (Berlin, Germany), Minisart NML syringe fil-
ters (0.2 µm pore size) by Sartorius (Goettingen,
Germany). Purified anti-mouse CD90.2 (Thy-1.2) anti-
body (clone 53-2.1) was obtained from BioLegend (San
Diego, CA, USA), x-well slides (2 wells on glass, detach-
able) from Sarstedt (Nuembrecht, Germany), block mag-
net Q-19-13-06-LN from supermagnete Webcraft
(Gottmadingen, Germany). Fab-TACS Gravity columns
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with adapter and flow restrictor were used from IBA's
Fab-TACS Gravity Kit (Goettingen, Germany). The water
used for all experiments came from a Siemens Ultra
Clear system (Evoqua Water Technologies, Guenzburg,
Germany).
Nanoparticle Synthesis
SPIONCitrate were synthesized according to a modified
protocol of Elbialy et al.25 Iron(II) chloride and iron(III)
chloride were dissolved in water in a molar ratio of 1:2
and stirred under an argon atmosphere to prevent oxida-
tion. Iron oxide was precipitated by the addition of ammo-
nia solution 25%. After 10 mins, 1 M sodium citrate
solution was added and the mixture stirred for 30 mins at
90 °C. To remove excess sodium citrate, the cooled
SPIONs were washed with acetone five times and then
dried under vacuum at room temperature. For application,
the dry stored particles were dissolved in water and filtered
sterile through a 0.2 μm-pore diameter syringe filter.
Nanoparticle Characterization
Iron Quantification
For determination of the iron concentration, atomic emis-
sion spectroscopy (AES) was used with an Agilent 4200
MP-AES (Agilent Technologies, Santa Clara, CA, USA).
A commercially available iron solution (1000 mg/L, Bernd
Kraft, Duisburg, Germany) served as an external standard.
Samples were dissolved with nitric acid 65% at 95 °C and
diluted with water. The analysis was performed using
independent triplicates.
Particle Size
Dynamic light scattering (DLS) was performed with a
Zetasizer Nano ZS (Malvern Panalytical, Almelo,
Netherlands) to determine the hydrodynamic particle size at
25 °C in water (refractive index 1.33, viscosity 0.8872
mPa·s) and in DMEM cell culture medium, supplemented
with 10% fetal calf serum (FCS), 1% L-glutamine and 1%
penicillin/streptomycin solution (refractive index 1.335,
viscosity 1.1100 mPa·s). The measurements were done in
triplicate at an iron concentration of 50 µg/mL.
In addition, images of the particles were taken with a Zeiss
Auriga scanning electron microscope (SEM) (Carl Zeiss,
Oberkochen, Germany) with an acceleration voltage of 1.5 kV.
Zeta Potential
The Zetasizer Nano ZS was also used to check the parti-
cles' aqueous zeta potential with 78.5 as the dielectric
constant. Measurements were done in triplicate at an iron
concentration of 50 µg/mL and pH 6.6.
Magnetic Susceptibility
As an indicator for the SPIONs' magnetizability, the mag-
netic susceptibility at an iron concentration of 1 mg/mL
was measured with a MS2G magnetic susceptibility meter
(Bartington Instruments, Oxfordshire, UK).
Blood Stability
The stability of the nanoparticles in blood was tested in
freshly drawn human whole blood stabilized with EDTA or
citrate according to the protocol published by Lugert et al.26
Blood (200 µL) was incubated with 100 µL SPIONs (2 mg
iron/mL) for 45 mins. Water served as a negative control,
and SPIONs with a coating of lauric acid and aminated
human serum albumin served as a positive control.24 Two
microliters of each sample were streaked on a glass slide
and microscoped using a Zeiss Axio Observer Z1 micro-
scope (Carl Zeiss, Jena, Germany). The use of human
material (blood) was approved by the local ethics commit-
tee at Universitätsklinikum Erlangen (reference no. 257-14
B) and written informed consent was obtained from volun-
tary donors.
Cell Culture
The cell line EL4 (ATCC TIB-39) consisted of T lym-
phocytes from mouse lymphoma and was non-adherent.
Cells were cultured in DMEM supplemented with 10%
FCS, 1% L-glutamine and 1% penicillin/streptomycin
solution at 37 °C in humidified 5% CO2 atmosphere.
Cells were passaged twice a week. The MUSE Cell
Analyzer (Merck, Darmstadt, Germany) was used to
determine cell count and viability.
Cell Toxicity
Flow cytometry was used to examine possible toxic effects of
SPIONCitrate on cell viability.27 For this purpose, 5×104 cells
in 1 mL medium were seeded in triplicate in 24-well plates
and incubated with SPIONs at iron concentrations of 25, 50,
75 or 100 µg/mL or the same volume water as a control.
Immediately after seeding as well as after incubation for 24
and 48 hrs, a sample of 50 µL was taken from each well and
stained with a mixture containing 1 µL/mL Hoechst 33342
(Hoe, 10 mg/mL), 2 µL/mL Annexin A5 FITC conjugate
(AxV), 66.7 ng/mL propidium iodide (PI) and 0.4 µL/mL
DiIC1(5) (1,1′-dimethyl-3,3,3′,3′-tetramethylindodicarbo-
cyanine iodide, DiI, 10 µM) in Ringer's solution. Hoe was
Dovepress Mühlberger et al
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used to identify cells by staining their nucleus, and DiI
staining was done additionally to determine the integrity of
the mitochondrial membrane potential. With AxV and PI,
apoptotic and necrotic cells were detected. After 20 mins of
incubation at 4 °C under light protection, fluorescence was
measured with a Gallios flow cytometer and analyzed with
Kaluza 1.2 Analysis Software (Beckman Coulter Life
Sciences, Indianapolis, IN, USA).
A 2′,7′-dichlorofluorescin diacetate (DCFH-DA) assay
was performed to check whether reactive oxygen species
(ROS), e.g. by lipid peroxidation, were a cause of particle
toxicity. The EL4 cells were stained with 40 µMDCFH-DA in
phosphate-buffered saline (PBS) with 5% FCS for 5 mins
under light protection, washed with medium and then resus-
pended in medium at a concentration of 2×105 cells/mL. In
triplicate, 180 µL cell suspensionwas seeded in a 96-well plate
and mixed with 20 µL water, 1 mM hydrogen peroxide or
SPIONCitrate at iron concentrations of 25, 50, 75 or 100 µg/mL.
Immediately after seeding as well as after incubation for 6, 24
and 48 hrs, a sample of 50 µL was taken from each well and
stained with a mixture containing 66.7 ng/mL PI and 0.4 µL/
mLDiI (10 µM) in Ringer's solution. After 30 mins of incuba-
tion at 37 °C under light protection, fluorescence was mea-
sured with a Gallios flow cytometer and analyzed with Kaluza
1.2 Analysis Software.
Cellular Uptake Of SPIONCitrate
Three methods were combined to obtain information about
the particle uptake into the cells: analysis of the cell
granularity, staining with Lucifer Yellow (LY) and spectro-
scopical quantification of iron content.
Cell Granularity
As part of the cell viability test via flow cytometry as
described above, the values of the side scatter (SSc) were
obtained as a parameter for cell granularity which gets
altered by adhesion or internalization of SPIONs.28
Lucifer Yellow Staining
For estimating whether particles were adsorbed to the cell
surface or internalized into the cell, staining with Lucifer
Yellow, a membrane-impermeable fluorescent dye that
gets co-ingested with particles, was done.29,30 Under
light protection, 5×104 cells in 1 mL medium containing
2 µg LY were seeded in triplicate in 24-well plates and
incubated with SPIONs at iron concentrations of 25, 50,
75 or 100 µg/mL or the same volume water as a control.
Immediately after seeding as well as after incubation for
24 and 48 hrs, a sample of 50 µL was taken from each well
and stained with a mixture containing 1 µL/mL Hoe (10
mg/mL) and 0.4 µL/mL DiI (10 µM) in Ringer's solution.
After 20 mins of incubation at 4 °C under light protection,
fluorescence was measured with a Gallios flow cytometer
and analyzed with Kaluza 1.2 Analysis Software.
Quantification Of Iron Content
For quantification of particle uptake into cells, 107 cells
were seeded in 20 mL medium in a T75 cell culture flask
and incubated for 24 hrs with SPIONCitrate at iron con-
centrations of 50, 75 or 100 µg/mL or the same volume
of water as a control. After incubation, loaded cells had
to be separated from excess nanoparticles by means of a
specifically developed and recently published immunoaf-
finity chromatographic method.31 In short, a Fab-TACS
Gravity column was prepared and loaded with the
desthiobiotinylated anti-mouse CD90.2 antibody. The
SPION/cell suspension was transferred to the column
and allowed to run through completely allowing the
cells to bind to the antibody. After washing with 37 °C
warm PBS with 2% FCS and 0.5 mM EDTA, cells were
eluted in two steps with 37 °C warm 10 mM biotin in
DMEM cell culture medium. The eluted cells in biotin
solution were centrifuged for 5 mins at 300 RCF, the
supernatant was removed and the cells were resuspended
in fresh medium. Cell count of the purified loaded cells
was determined by MUSE Cell Analyzer. The volume
corresponding to 5×105 cells was taken in triplicate from
each sample. By centrifugation at 300 RCF for 5 mins, a
cell pellet was formed and washed twice with PBS. The
purified pellet was dried for 30 mins at 95 °C and lyzed
with nitric acid 65% at 95 °C. After diluting the samples
with water, the iron content was measured by AES with
an Agilent 4200 MP-AES using a commercially available
iron solution (1000 mg/L, Bernd Kraft, Duisburg,
Germany) as an external standard.
Magnetizability Of SPIONCitrate-Loaded
EL4 Cells
The feasibility to control SPIONCitrate-loaded T cells using
a magnetic field was investigated in two experiments.
2×107 Cells were seeded in 40 mL medium in a T150
cell culture flask and incubated for 24 hrs with
SPIONCitrate at an iron concentration of 75 µg/mL. The
same volume of water served as a negative control. After
incubation, 107 loaded cells were separated from excess
Mühlberger et al Dovepress
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nanoparticles by means of the previously described immu-
noaffinity chromatographic method.
Incubation On Magnetic Plate
Each 5×106 cells of purified, unwashed and control cells
were stained with 10 µL 0.5% crystal violet solution. After
incubation at 37 °C for 10 mins, cells were washed with
PBS with 2% FCS and 0.5 mM EDTA and resuspended in
500 µL medium. The cell suspensions were each transferred
to one well of a 24-well plate and incubated for 48 hrs on
top of a plate similar to a 96-well plate containing 0.5 T
magnets as shown in Figure 7. The magnet's magnetic flux
density was determined by measuring n = 12 magnets with
a Hall effect magnetometer (FM302 with AS-NTM, Projekt
Elektronik Mess- und Regelungstechnik, Berlin, Germany).
Video Of Magnetic Attraction
Each 5×105 cells of purified, unwashed and control cells
were transferred to one well of a two-well chamber on a
glass slide at a total volume of 500 µL. The slide was
placed under an Axio Observer Z.1 microscope (Carl
Zeiss, Jena, Germany). A lengthwise magnetized block
magnet was placed in the second well and cells were
filmed at 10× magnification at the edge of the two-well
barrier.
Statistical Analysis
For data shown in Figures 3–5, single-factor ANOVA
analysis was performed in MS Excel (Microsoft,
Redmond, WA, USA). Significant results (p < 0.05) were
further processed with the Scheffé test as a post hoc test.
In Figures 3–5, asterisks were used to mark statistical
significance between control and treatment groups.
Further results between treatment groups can be found
in supplementary information S1.
For Figure 6, an unpaired Student's t-test in MS Excel
was used for statistical analysis. Degree signs were used to
mark statistical significance levels between control and
treatment groups (°p < 0.05, °°p < 0.005), number signs
between treatment groups (#p < 0.05, ##p < 0.005).
Results And Discussion
Nanoparticle Synthesis And
Characterization
The hydrodynamic diameter, the zeta potential, the mag-
netic susceptibility and the blood stability were used for
the characterization of SPIONCitrate.
Physicochemical Properties
In water, the particles had a mean hydrodynamic diameter
of 58 nm measured as Z-average and a corresponding PDI
of 0.149. In cell culture medium as used for experiments,
the mean diameter increased to 430 ± 44 nm due to
colloidal instability and thus agglomeration.
A SEM image of the particles is shown in Figure 1.
The zeta potential of the particles in water at pH 6.6
was −48.5 ± 0.5 mV. It was not possible to determine the
zeta potential in the cell culture medium since the mea-
sured values corresponded to the values of the pure med-
ium. This was a consequence of the high salt content of the
medium and the resulting high conductivity.
The magnetic susceptibility served as a parameter for
particles' magnetizability. The particles were diluted to an
iron concentration of 1 mg/mL and had a magnetic suscept-
ibility of 4.08×10−3. The original publication by Elbialy et al
used a ratio 5:6 of iron(II) chloride to iron(III) chloride.22 This
ratio resulted in a magnetic susceptibility of 3.20×10−3. In
order to achieve higher magnetic susceptibility and thus better
magnetizability of SPIONCitrate, we changed the ratio to 1:2.
Blood Stability
Since the stability of the nanoparticles in the blood is an
important factor for future in vivo application, it was
investigated after a protocol published by Lugert et al
Figure 1 SEM picture of SPIONCitrate. The picture of freeze-dried SPIONCitrate was
taken with a Zeiss Auriga SEM (Carl Zeiss, Oberkochen, Germany) with an accel-
eration voltage of 1.5 kV.
Abbreviations: SPION, superparamagnetic iron oxide nanoparticle; SEM, scanning
electron microscope.
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and Poller et al.26,32 We used freshly drawn human blood,
which was stabilized against coagulation with citrate or
EDTA. Water served as a negative control, and SPIONs
coated with lauric acid and aminated human serum albu-
min served as a positive control. As shown in Figure 2, the
citrate-coated particles and the negative control showed
neither signs of agglomeration nor lysis of erythrocytes.
The aminated particles agglomerated and lyzed erythro-
cytes. Hence, as far as blood stability is concerned,
SPIONCitrate is potentially suitable for future in vivo
applications.
Toxicity
The MTT test is often used to examine cytotoxic
effects.33 Due to the dark color of the nanoparticles, it
was not possible to investigate the toxic effects of the
SPIONs to the cells with common photometric assays
such as the MTT test.34 Therefore, the influence of the
particles on cell viability and proliferation at various
particle concentrations (25 to 100 µg Fe/mL) was ana-
lyzed by flow cytometry according to a protocol of
Munoz et al.27 The cells were stained with Hoe, AxV,
PI and DiI and their fluorescence was measured by flow
cytometry. Due to the cell nuclei staining by Hoe, the
aggregated SPIONs within the medium were excluded
from analysis, so that only cells were investigated. As
shown in Figure 3, AxV and PI were used to differenti-
ate between viable (AxV-PI-, green), early apoptotic
(AxV+PI-, blue) and late apoptotic/necrotic (PI+, red)
cells.
After 24 hrs, low toxic effects were observed at all
particle concentrations. The viability only decreased
from 86.8% to 80.3% at the highest concentration of
100 µg Fe/mL. At 48 hrs, the toxic effects of the
particles increased further. However, the percentage of
viable cells was still above 70% at all concentrations.
In subsequent experiments, we used a particle concen-
tration of 75 µg Fe/mL, since at this concentration, the
viability of the cells stayed above 80% after 24 hrs of
incubation and only slightly decreased to around 80%
after 48 hrs.
In the observed time frame, cell proliferation of EL4
control cells was linear and tripled every 24 hrs. In
contrast, cell proliferation of SPION-treated cells was
slightly impaired after 24 hrs. After 48 hrs, the effect of
SPIONs on cell proliferation became more obvious. The
amount of cells in SPION-treated samples was signifi-
cantly lower than in the control samples. Moreover, the
decrease in cell numbers was clearly dose-dependent,
reducing the cell number to around 6200 events at the
highest SPION concentration compared to approximately
12,000 events in the control sample.
Figure 2 Stability of SPIONCitrate in blood. SPIONCitrate (left) and water used as negative control (right) were stable in EDTA (upper row) and citrate (lower row)
anticoagulated blood. Contrary to the aminated particles used as positive control (middle), which aggregated (marked by arrows), SPIONCitrate did not show agglomeration.
Abbreviations: EDTA, ethylenediaminetetraacetic acid; SPION, superparamagnetic iron oxide nanoparticle
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In summary, SPIONCitrate were clearly less cytotoxic
than the previously used lauric acid–coated SPIONs and
were tolerated at least as well as the lauric acid–coated
SPIONs with additional albumin coating.24
As a possible cause for the slight toxicity of
SPIONCitrate, the formation of reactive oxygen species,
e.g. by lipid peroxidation, was investigated using a
DCFH-DA assay.35 The non-fluorescent DCFH-DA passes
through the cell membrane. The two acetate groups are
cleaved off by intracellular esterases so that the dye can no
longer pass through the cell membrane. In the presence of
ROS, dichlorofluorescin (DCFH) is oxidized to strongly
fluorescent dichlorofluorescein (DCF) whose fluorescence
can be measured with the flow cytometer.36,37
As shown in Figure 4, water was used as a negative control
and 1 mM hydrogen peroxide as a ROS-inducing positive
control. Immediately after addition to the cell suspension, the
hydrogen peroxide controls showed a strongDCFfluorescence
which indicated ROS-stressed cells. After 6, 24 and 48 hrs of
incubation, no viable cells were detectable anymore. In con-
trast, the water controls and different SPIONCitrate concentra-
tions did not show a significant increase in the proportion of
ROS-stressed cells. Therefore, the generation of reactive
oxygen species as a cause for the toxicity of the particles can
be eliminated.
Cellular Uptake Of SPIONCitrate
Flow Cytometry
In order to obtain information about the uptake of
SPIONCitrate into the cells or their adhesion to the cell
surface, we first evaluated the side scatter values obtained
during the flow cytometry toxicity measurements. The
side scatter provides information about the cellular gran-
ularity, which increases in the case of particle uptake or
adsorption.28 As shown in Figure 5A, the intensity of the
side scatter already increased depending on the concen-
tration in the first 5 mins after the addition of the particles
to the cells (0 hr, white). At an iron concentration of 75
µg/mL and 24 hrs of incubation, the side scatter intensity
roughly doubled compared to the control samples. After
48 hrs, the SPION-treated cells showed a slight decrease
in their side scatter intensity compared to the 24-hr
values, indicating a possible exocytosis of particles or/
and a division of the cellular particle load during cell
division.
Figure 3 Determination of biocompatibility by flow cytometry. In the beginning, after 24 hrs and after 48 hrs of the incubation of EL4 cells with SPIONCitrate, cells were stained with
Hoe to exclude excess particles from analysis and with AxV and PI for detection of apoptotic (AxV+PI-, blue) and necrotic (PI+, red) cells. The results were displayed as percentage of
cell count (A) and as relative cell count (B). The experimentwas performed in triplicate in at least three independent experiments. Themean values with standard deviations are shown.
Numeric data for this figure can be found in supplementary information S2. Significance of viable cells (AxV-PI-) compared to control is represented by asterisks.
Abbreviations: AxV, Annexin A5 FITC conjugate; Hoe, Hoechst 33342; PI, propidium iodide; SPION, superparamagnetic iron oxide nanoparticle.
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Since the side scatter analysis provided no information
about whether the SPIONs were absorbed into the cells or
only adhered to the cell surface, staining with the fluorescent
dye Lucifer Yellowwas performed.29 The cells were incubated
in medium containing LY with particles at different iron con-
centrations (0–100 µg/mL) for 24 and 48 hrs. If particles are
incorporated into cells, LY is simultaneously co-ingested,
resulting in an increase of fluorescencewhich can bemeasured
by flow cytometry.30 To analyze the LY fluorescence intensity
by flow cytometry, the cells were stained with Hoe and DiI
after 0, 24 and 48 hrs to allow the gating of viable cells (Hoe
+DiI+) only. As shown in Figure 5B, increased fluorescence
was observed after 24 hrs and also after 48 hrs at all iron
concentrations. In addition to the measured LY fluorescence
in control samples, which is due to a general uptake by ubiqui-
tous endocytosis, the incubation with SPION concentrations ≤
50 µg Fe/mL led to a further concentration-dependent increase
of the LY fluorescence.38 At concentrations above 50 µg Fe/
mL, the fluorescence intensity did not increase further, indicat-
ing the achievement of a maximal loading capacity, a quench-
ing of the fluorescence by the internalized particles or the
masking by extracellular membrane-bound particles.
Figure 4 Detection of formation of reactive oxygen species by flow cytometry. To
check whether SPIONCitrate leads to the formation of ROS, the EL4 cells were stained
with DCFH-DA.When ROS is generated, DCFH is oxidized to DCF, which has a strong
fluorescent effect. In the beginning, after 6 hrs, 24 hrs and after 48 hrs of incubation with
SPIONCitrate, cells were additionally stained with DiI and PI for detection of viable cells.
The results were displayed as relative cell count (A) and as percentage of cell count (B).
The experiment was performed in triplicate in at least two independent experiments.
The mean values with standard deviations are shown. Significance of stressed cells
compared to hydrogen peroxide 1 mM is represented by asterisks.
Abbreviations: DCF, dichlorofluorescein; DCFH, dichlorofluorescin; DCFH-DA,
2′,7′-dichlorofluorescin diacetate; DiI, DiIC1(5) (1,1′-dimethyl-3,3,3′,3′-tetramethy-
lindodicarbocyanine iodide); PI, propidium iodide; ROS, reactive oxygen species;
SPION, superparamagnetic iron oxide nanoparticle.
Figure 5 Determination of particle uptake and/or adhesion by flow cytometry.
In the beginning, after 24 hrs and after 48 hrs of the incubation of EL4 cells with
SPIONCitrate, cells were stained with Hoe to exclude excess particles from
analysis and with DiI to detect viable cells with intact mitochondrial membrane
potential. (A) Side scatter values of viable cells were analyzed for changes in cell
granularity, which occurred with uptake and adhesion of particles. (B) The
fluorescent dye LY was added to the cell culture medium before incubation of
cells with nanoparticles. During particle uptake into the cell, LY was co-ingested
and hence served as a parameter for particle uptake. The experiments shown in
this figure were performed in triplicate in at least three independent experi-
ments. The mean values with standard deviations are shown. Significance of
treated cells compared to control at the same time point is represented by
asterisks.
Abbreviations: DiI, DiIC1(5) (1,1′-dimethyl-3,3,3′,3′-tetramethylindodicarbocya-
nine iodide); Hoe, Hoechst 33342; LY, Lucifer Yellow; SSc, side scatter; SPION,
superparamagnetic iron oxide nanoparticle.
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However, the incorporation of LY into the cells was signifi-
cantly higher in the presence of particles compared to control
samples, indicating a cellular uptake mechanism for SPIONs
and consequently the existence of intracellular SPIONs.
However, the existence of strongly membrane-bound
SPIONs could not be completely ruled out.
The combined evaluation of the side scatter and LY
staining data suggested that the particles were both incorpo-
rated into the cells and adsorbed to the cell surface. Based on
the toxicity tests, the incubation time was fixed to 24 hrs,
since 48 hrs of incubation led to lower granularity and LY
fluorescence as well as a higher number of necrotic cells.
Quantification Of Iron Content
In order to be able to reliably control SPION-loaded cells by a
magnetic field, it is necessary to sufficiently load the cells with
particles. The amount of cellular and strongly cell membrane-
bound particles was particularly relevant, as slightly adhered
particles could be easily removed by various factors such as
shear stress, washing or diffusion. To quantify the average iron
content per cell, EL4 cells were incubated for 24 hrs with
SPIONs at an iron concentration of 75 µg/mL and purified
using a self-developed immunoaffinity chromatographic
method mentioned above. Subsequently, 5×106 cells were
washed and centrifuged before the cell pellets were dried,
lyzed with HNO3 65%, diluted with water and the iron content
measured by AES. As shown in Figure 6, the particle-free
control cells contained an average of 0.12 ± 0.10 pg iron per
cell, the unwashed loaded cells 2.11 ± 0.45 pg iron per cell, as
excess SPIONs were also measured. After purification, the
loaded cells contained 1.02 ± 0.17 pg iron per cell, which was
comparable with values already obtained in other studies.39–41
Theoretically, methods such as electroporation or trans-
fection reagents like lipofectamine could be used to
increase the transport of the particles into the cell and
achieve higher values. However, these methods would
have a negative effect on cell viability and are therefore
not suitable for patient-specific application.42–44
Magnetizability Of SPIONCitrate-Loaded
EL4 Cells
Twodifferent experimentswere performed to checkwhether the
cells loaded with SPIONCitrate can be magnetically controlled.
The first was based on SPIONCitrate-loaded cells stained
with crystal violet and incubation on a magnetic plate,
whereas the second experiment used live cell imaging to
prove the magnetic attraction of cells.
As shown in Figure 7, purified, unwashed and control cells
were incubated in a 24-well plate for 48 hrs on top of a 96-well
plate supplemented with small magnets. Each well of the 24-
well plate was placed on four magnets of the magnetic plate.
Every magnet had a magnetic flux density of 499.6 ± 6.2 mT
directly on its surface. This value was determined by
measuring n = 12 magnets with a Hall effect magnetometer
(FM302 with AS-NTM, Projekt Elektronik Mess- und
Regelungstechnik, Berlin, Germany). To visualize where the
cells sediment in thewell, theywere stainedwith crystal violet.
Due to faint light conditions and surface reflections, the 24-
well plate was carefully removed from the magnet plate after
the 48 hrs-incubation period and photographed on an LED
light plate (slimlite LED, Kaiser Fototechnik, Buchen,
Germany). The particle-free control cells showed sedimenta-
tion of the cells over the entirewellwith a tendency towards the
middle of the well. In contrast, the purified as well as the
unwashed loaded cells sedimented mainly in the area of the
four magnets, which proves themagnetizability of the SPION-
loaded cells and attraction by external magnets.
In order to observe and quantify the attraction of the loaded
cells to a magnet more closely, the process was filmed under a
microscope at 10× magnification. Supplementary Video 1
shows purified EL4 cells incubated with SPIONCitrate at an
iron concentration of 75 µg/mL. Without the presence of a
Figure 6 Quantification of SPION uptake into cells. EL4 cells were incubated
for 24 hrs with SPIONCitrate at an iron concentration of 75 µg/mL. Cell pellets
of purified, unwashed and control cells were counted, lyzed and their iron
content measured by AES. The purification process led to a significantly lower
amount of iron in the pellet of the washed cells, but these, like the unwashed
cells, still contained significantly more iron than the control cells. The experi-
ment shown in this figure was performed in six independent experiments. The
mean values with standard deviations are shown. Significances of treated cells
compared to control are represented by degree signs (°°p < 0.005), signifi-
cance of purified cells compared to unwashed cells is represented by number
signs (##p < 0.005).
Abbreviations: AES, atomic emission spectroscopy; SPION, superparamagnetic
iron oxide nanoparticle.
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magnet, the cells were almost stationary. In Supplementary
Video 2, a longitudinally magnetized block magnet was placed
in the second chamber, as can be seen from the juddering of the
video image.With theHall effectmagnetometer, amagneticflux
density of about 240 mT could be measured at the separating
barrier of the two chambers on the side of the cells. In the
presence of the magnet, the majority of the cells were immedi-
ately attracted in the direction of the magnetic field gradient.
Therewere several reasonswhy the cells haddifferent velocities.
Firstly, themicroscopicfilmswere performedby focusing on the
slide`s surface, since more cells can be observed in that plane
due to cell sedimentation.However, sedimentation to the surface
leads to cellular adhesion and friction, inhibiting the efficiency
of the magnetic attraction. Secondly, a homogeneous loading of
cells with SPIONs was not possible. Hence, cells with a high
SPION load could be attracted better and faster than cells with
lower SPION loading. Finally, the strength of themagnetic field
itself decreasedwith increasing distance, so that the acceleration
and speed of the cells depended on the distance to the magnet.
The software “Tracker VideoAnalysis andModeling Tool”was
used to randomly determine the speed of the respective cells at
various points in the video. The velocity of the fastest cell
examined was about 400 µm/s.
Our video recordings confirmed that it was well possi-
ble to load T cells with SPIONCitrate without external
intervention so that they could be controlled by means of
a magnetic field.
Due to its simplicity and cell compatibility, this method
of magnetically controlling T cells could also be used in
the future to extend CAR T cell therapy to solid tumors.
Previously approved CAR T cell preparations such as
Kymriah or Yescarta only target blood cancer and are
administered systemically with up to 600 million cells,
which can lead to severe side effects such as a cytokine
storm.45 If the CAR T cells were loaded with SPIONs,
solid tumors could be treated locally with a reduced
amount of cells, resulting in an extremely efficient therapy
with fewer side effects.46
Conclusion
In this study, we succeeded in developing a system of T
cells loaded with superparamagnetic iron oxide nanoparti-
cles, which can be controlled by an external magnet.
SPIONCitrate proved to be highly cytocompatible and also
stable in blood. The nanoparticles were sufficiently
absorbed into EL4 cells without external intervention,
and the cell/SPION suspension could be easily purified
from excess SPIONs by an immunoaffinity chromato-
graphic method.
This study creates a good starting point for the translation
of the methods to ex vivo applications and finally to magne-
tically controlled immune therapy using SPION-loaded pri-
mary T cells.
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